Sandoz Around the World Press Releases and News The latest news from Sandoz Around the World. Nick Haggar comments on Sandoz in Africa A shining example of successful locational policy Sandoz launches first-ever Japanese biosimilar, broadening access to medicines in second largest global market Sandoz launches Losartan potassium tablets Sandoz launches generic version of Valtrex Sandoz completes acquisition of Oriel Therapeutics, strengthening potential for global leadership in respiratory Lek one of the strongest development centers in Slovenia Lek first in Slovenia to offer generic rosuvastatin for lowering Sandoz continues to build oncology injectables portfolio with US launch of docetaxel injection, a ready-to-use version of Taxotere® Sandoz Group continues to lead German generics market in Q3 2011 Sandoz publishes 2013 Diversity & Inclusion Annual Report Sandoz launches imiquimod cream 5%, a generic version of Aldara® Sandoz introduces authorized generic version of Famvir® Sandoz launches meropenem for injection, USP, a generic version of Merrem® I.V. Sandoz ensures continued supply of levothyroxine sodium in Japan Sandoz launches Altavera®, a generic version of Nordette® Sandoz builds oral contraceptive portfolio with the launch of Loryna®, a generic version of YAZ® Sandoz launches a new, ready-to-use formulation of argatroban injection (in Sodium Chloride) First regional BioCamp in the Alpe-Adria region – excellent opportunity for top students to meet science and business Sandoz launches Syeda™, a generic version of Yasmin® Sandoz launches donepezil HCL tablets, a generic version of Aricept® Sandoz launches generic versions of Levaquin® Tablets and Levaquin® Injection Sandoz announces generic pharmaceuticals strategic alliance with Nipro Corporation in Japan Sandoz launches Letrozole, the generic version of Novartis’ Femara® Sandoz expands Omnitrope® offering with FDA approval for a sixth indication Sandoz expands US respiratory franchise with launches of Albuterol Sulfate and Ipratropium Bromide Sandoz expands differentiated portfolio in US to include Alcon’s Falcon generic Sandoz Group Sends Strong Signal to Discount Contract Market Sandoz launches voriconazole tablets, a generic version of Vfend® Sandoz enters local Cameroon production partnership to increase access to quality medicines in Sub-Saharan Africa Sandoz completes US offering of generic Lovenox® line with launch of enoxaparin sodium injection, USP vials Sandoz launches generic Lipitor® across EU countries Sandoz K.K. announces co-promotion of Somatropin BS S.C. Injection 5mg/10mg [Sandoz] with Nipro Pharma Corporation in Japan Sandoz launches voriconazole injection, the first generic version of Vfend® Alabama Supreme Court Rules in Favor of Sandoz in Medicaid Pricing Case Sandoz supports Zambian government in increasing access to high-quality, affordable medicines through Health Shops Manager of the Year 2012 is Vojmir Urlep Sandoz Biopharmaceuticals Opens New Cellular and Molecular Biology Laboratory in Mengeš Sandoz strengthens US portfolio with acquisition of four generic products from Watson/Actavis Sandoz calls for US industry collaboration to ensure patient access to critical biologic medicines Education and outreach increasing community’s access to medicines in Brazil Regional BioCamp 2013 – Young scientists get a firsthand glimpse of the world of pharmacy (video) Sandoz associates in Russia continue the spirit of Novartis Community Partnership Day Sandoz expands sterile penicillin production at Kundl site Sandoz opens new state-of-the-art development center in East Hanover, NJ Sandoz receives FDA approval for another new indication for Omnitrope® and launches Patient Assistance Program Sandoz US receives DGLCC Community Ally Award Lek, a Sandoz company, recognized for its work-life integration efforts Sandoz launches lansoprazole delayed-release orally disintegrating tablets (ODT), an authorized generic version of PREVACID® SoluTab Sandoz announces launch of piperacillin and tazobactam for injection, a generic version of Zosyn®